Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-20-000105

Options or other derivatives

  • CEO and President acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. CEO and President 2020-01-28 Grant or award · Stock Option (Right to Buy) +300,000 $0.46 $137,400 300,000 D
Loading xslF345X03/doc4_6489.xml…